N.

Titolo

PI e/o altri docenti coinvolti

SSD

Codice EudraCT

Codice EudraCT

Codice Clinical Trials.gov

Eventuale altro codice

Data di autorizzazione del comitato Etico

Data di effettivo avvio del Trial

1

Studio retrospettivo-osservazionale per ottimizzare la sequenza di trattamento per il carcinoma della prostata metastatico resistente alla castrazione nel paziente anziano con più di 75 anni e nel paziente con alto volume di malattia

Prof. Antonio Russo

MED/06

SPARTACUSS

2

The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC (BURAN)

Prof. Antonio Russo

MED/06

2019-000790-23

AN2025H0301

NCT04338399

14/06/2022

25/08/2022

3

CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy

Prof. Antonio Russo

MED/06

2021-004593-56

CAVE-2

NCT05291156

12/07/2022

05/09/2022

4

A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE)

Prof. Antonio Russo

MED/06

2020-005833-34

AL-DES-01

NCT04871282

12/12/2022

5

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Prof. Antonio Russo

MED/06

2022-500637-80

CGT 9486-21-301

NCT05208047

6

Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Nivolumab in Patients With Advanced Melanoma

Prof. Antonio Russo

MED/06

2019-002521-30

HBI-8000-303

NCT04674683

12/07/2022

19/10/2022

7

Studio osservazionale retrospettivo-prospettico su pazienti

italiani con melanoma trattati in setting adiuvante nella

Cohort MAP per valutare la sopravvivenza libera da

recidiva e la sopravvivenza globale

Studio MADAM (Maximing ADjuvAnt MAP)

Prof. Antonio Russo

MED/06

CDRB436BIT06 (MADAM)

14/09/2022

06/12/2022

8

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. (COLUMBUS-AD)

Prof. Antonio Russo

MED/06

2021-004310-19

W00090GE303 / EORTC-2139-MG

NCT05270044

12/07/2022

28/11/2022

9

Brightline-1: A Study to Compare BI 907828 With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

Prof. Antonio Russo

MED/06

2021-002392-20

1403-0008

NCT05218499

13/04/2022

25/05/2022

10

Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma (ISG-MCS)

Prof. Antonio Russo

MED/06

2019-003733-41

MCS

NCT04305548

12/07/2022

02/12/2022

11

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients (REVERT)

Prof. Antonio Russo

MED/06

2020-002533-14

REVERT

NCT05396807

13/04/2022

12

Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP)

Prof. Andrea Cortegiani

MED/41

2015-002346-14

19/10/2022

05/01/2023

13

Cuff Pressure Control and Evacuation of Subglottic Secretions To Prevent Pneumonia

Prof. Andrea Cortegiani

Prof. Antonello Giarratano

MED/41

NCT05403320

14/06/2022

01/07/2022

14

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma (PrE0505)

Prof. Andrea Cortegiani

Prof. Antonello Giarratano

MED/41

NCTO5089695

15/02/2022

03/03/2022